
FAO
UN Rome-based food and farming agency; its 2026 AMR report projects $318bn in livestock losses if antibiotic resistance goes unchecked.
Last refreshed: 9 June 2026 · Appears in 1 active topic
How much will cheap livestock antibiotics cost the global food system by 2040?
Timeline for FAO
Published 3 June report costing AMR inaction at $318bn by 2040 in livestock production losses
Pandemics and Biosecurity: FAO costs drug-resistance inaction at $318bn- What did the FAO say about antibiotic use in livestock in 2026?
- FAO's 3 June 2026 report projected global livestock antimicrobial use rising 30% by 2040 versus 2019. Under a high-resistance scenario, cumulative livestock production losses would reach $318 billion by 2040, about six times the cost of acting now.Source: FAO
- Why does so much antibiotic use happen in livestock rather than human medicine?
- Most global antimicrobial use occurs in livestock because cheap broad-spectrum antibiotics are a routine production input that keeps crowded herds healthy and productive. FAO projects this use rising 30% by 2040 as meat demand grows in lower-middle-income countries.Source: FAO
- What is the FAO and what does it do on antimicrobial resistance?
- FAO is the UN agency for food, agriculture, and farming, founded in 1945 and headquartered in Rome. On AMR, it operates alongside WHO and WOAH in the Tripartite framework, addressing antibiotic use in animals and food systems rather than human medicine.Source: FAO
- How does antimicrobial resistance in livestock affect humans?
- Resistance genes in livestock bacteria can transfer to human pathogens via the food chain, direct animal contact, or environmental spread. FAO projects $318bn in livestock production losses by 2040 under a high-resistance scenario, with knock-on food supply and price consequences for human populations.Source: FAO
Background
The Food and Agriculture Organization (FAO) published a report on 3 June 2026 projecting global antimicrobial use in livestock rising 30% by 2040 against a 2019 baseline, and cumulative livestock production losses reaching $318 billion by 2040 under a high-resistance scenario. That figure runs approximately six times the cost of acting now. The report attaches an economic argument to the WHO Global Action Plan on AMR adopted in May 2026, routing the same problem through food-security economics to reach agriculture and finance ministries that a mortality-based framing never reached.
FAO is the United Nations agency mandated to lead international efforts on food security, agriculture, forestry, and fisheries. Founded in 1945 and headquartered in Rome, it counts 195 member states and territories. On AMR, FAO operates as one of the three principals in the Tripartite framework alongside WHO and the World Organisation for Animal Health (WOAH, formerly OIE), recognising that most antimicrobial use globally occurs in livestock, not human medicine. The 30% projected rise in livestock antibiotic use by 2040 reflects rising meat demand in lower-middle-income countries, where cheap broad-spectrum antibiotics are a production input rather than a last resort.
FAO's framing of AMR as a food-security and macroeconomic issue, rather than primarily a public health one, is strategic. Cheap antibiotics keep crowded herds productive; resistance follows the use; and pricing the $318bn production loss makes the case to ministries of agriculture and finance that had been peripheral to AMR governance. That 6:1 inaction-to-action cost ratio is the lever, reframing mitigation spending as loss avoidance for the food system rather than as public-health expenditure.